Clinical Effectiveness and Application Strategies of Bismuth Quadruple Therapy: Analysis of the European Helicobacter Pylori Registry (Hp-EuReg).
作者信息
Choi Hyun Ho
机构信息
Division of Gastroenterology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
出版信息
Korean J Helicobacter Up Gastrointest Res. 2025 Sep;25(3):305-306. doi: 10.7704/kjhugr.2025.0040. Epub 2025 Sep 1.
Abstract
摘要
相似文献
1
Clinical Effectiveness and Application Strategies of Bismuth Quadruple Therapy: Analysis of the European Helicobacter Pylori Registry (Hp-EuReg).铋剂四联疗法的临床疗效及应用策略：欧洲幽门螺杆菌登记研究（Hp-EuReg）分析
Korean J Helicobacter Up Gastrointest Res. 2025 Sep;25(3):305-306. doi: 10.7704/kjhugr.2025.0040. Epub 2025 Sep 1.
2
Effectiveness and safety of first-line empirical Helicobacter pylori eradication regimens in Switzerland: an interim analysis from a prospective multicentre registry (Hp-EuReg).瑞士一线经验性幽门螺杆菌根除方案的有效性和安全性：一项前瞻性多中心登记研究（Hp-EuReg）的中期分析
Swiss Med Wkly. 2025 Jul 14;155:4191. doi: 10.57187/s.4191.
3
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for infection between 2013 and 2021: results from the European registry on management (Hp-EuReg).2013年至2021年间含铋四联疗法治疗幽门螺杆菌感染的使用情况、有效性及安全性的演变：欧洲幽门螺杆菌管理登记研究（Hp-EuReg）结果
Gut. 2024 Dec 10;74(1):15-25. doi: 10.1136/gutjnl-2024-332804.
4
First-Line Prescriptions and Effectiveness of Eradication Treatment in Ireland over a 10-Year Period: Data from the European Registry on Management (Hp-EuReg).爱尔兰10年间根除治疗的一线处方及有效性：来自欧洲管理登记处（Hp-EuReg）的数据
Antibiotics (Basel). 2025 Jul 5;14(7):680. doi: 10.3390/antibiotics14070680.
5
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg).幽门螺杆菌根除治疗的指征及其对处方和有效性的影响（Hp-EuReg）
Helicobacter. 2024 Jul-Aug;29(4):e13111. doi: 10.1111/hel.13111.
6
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management.质子泵抑制剂剂量和疗程在幽门螺杆菌根除治疗中的作用：来自欧洲幽门螺杆菌管理登记处的结果。
United European Gastroenterol J. 2024 Feb;12(1):122-138. doi: 10.1002/ueg2.12476. Epub 2023 Dec 4.
7
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg).铋四联疗法联合四环素或多西环素与三联单胶囊作为幽门螺杆菌感染的三线挽救治疗：欧洲幽门螺杆菌注册研究（Hp-EuReg）的西班牙数据。
Helicobacter. 2020 Oct;25(5):e12722. doi: 10.1111/hel.12722. Epub 2020 Jul 13.
8
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg).欧洲幽门螺杆菌管理研究注册（Hp-EuReg）5000 例患者的经验二线治疗。
Clin Gastroenterol Hepatol. 2022 Oct;20(10):2243-2257. doi: 10.1016/j.cgh.2021.12.025. Epub 2021 Dec 23.
9
Effectiveness and Safety of First-Line Non-Bismuth Quadruple Concomitant Therapy Versus Single-Capsule Bismuth Quadruple Therapy.一线非铋剂四联联合疗法与单粒胶囊铋剂四联疗法的有效性和安全性
Aliment Pharmacol Ther. 2025 Oct;62(8):809-820. doi: 10.1111/apt.70261. Epub 2025 Jul 4.
10
The Helicobacter pylori AI-clinician harnesses artificial intelligence to personalise H. pylori treatment recommendations.幽门螺杆菌人工智能临床助手利用人工智能对幽门螺杆菌治疗建议进行个性化定制。
Nat Commun. 2025 Jul 14;16(1):6472. doi: 10.1038/s41467-025-61329-5.
本文引用的文献
1
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.美国胃肠病学会临床指南：幽门螺杆菌感染的治疗
Am J Gastroenterol. 2024 Sep 1;119(9):1730-1753. doi: 10.14309/ajg.0000000000002968. Epub 2024 Sep 4.
2
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for infection between 2013 and 2021: results from the European registry on management (Hp-EuReg).2013年至2021年间含铋四联疗法治疗幽门螺杆菌感染的使用情况、有效性及安全性的演变：欧洲幽门螺杆菌管理登记研究（Hp-EuReg）结果
Gut. 2024 Dec 10;74(1):15-25. doi: 10.1136/gutjnl-2024-332804.
3
Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020.韩国 2020 年幽门螺杆菌感染治疗的循证指南。
Korean J Intern Med. 2021 Jul;36(4):807-838. doi: 10.3904/kjim.2020.701. Epub 2021 Jun 8.
4
Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Eradication?在根除方面，钾离子竞争型酸阻滞剂真的优于质子泵抑制剂吗？
Gut Liver. 2021 Nov 15;15(6):799-810. doi: 10.5009/gnl20242.
5
European Registry on management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients.欧洲管理登记处（Hp-EuReg）：5 年和 21533 例患者一线经验性根除处方的模式和趋势及其结果。
Gut. 2021 Jan;70(1):40-54. doi: 10.1136/gutjnl-2020-321372. Epub 2020 Sep 21.
6
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 V/佛罗伦萨共识报告。
Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.
Zotero 插件